DigestRedComo funciona
Red
/
Empresas
Ka
No verificado

Kairos Pharma, Ltd

Sobre qué escribimos

BiotecnologíaCienciaFarmacéuticaOncologíaSalud

22 Comunicados de prensa

Ver todos los comunicados de prensa
20/10/2025
Oncología
Salud
Ciencia
Farmacéutica
Biotecnología
Eventos
Industria
Kairos Pharma Presents on Phase 2 Trial of ENV-105 in Advanced Prostate Cancer at European Society Medical Oncologists (ESMO) Meeting
Fuente
Kairos Pharma, Ltd
Editor
Business Wire
1.00
0
07/10/2025
Salud
Ciencia
Farmacéutica
Oncología
Eventos
Kairos Pharma to Present Positive Safety and Efficacy Data from Phase 2 Prostate Cancer Trial at ESMO 2025
Fuente
Kairos Pharma, Ltd
Editor
Business Wire
1.00
0
18/09/2025
Farmacéutica
Salud
Oncología
Medicina - Varios
Web y redes sociales
Industria
Kairos Pharma Announces Positive Interim Efficacy Analysis of Phase 2 Trial of ENV105 in Advanced Prostate Cancer with Median Progression Free Survival of Over One Year
Fuente
Kairos Pharma, Ltd
Editor
Business Wire
1.00
0
11/09/2025
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Eventos
Finanzas
Web y redes sociales
Kairos Pharma Announces Virtual KOL Event to Provide Perspectives on ENV105 Interim Efficacy Results in Advanced Prostate Cancer
Fuente
Kairos Pharma, Ltd
Editor
Business Wire
1.00
0
03/09/2025
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Eventos
Ferias y Congresos
Industria
Kairos Pharma Announces Presentation of New Phase 1 Data on ENV105 Combination Therapy in Non-Small Cell Lung Cancer at the World Lung Cancer Conference September 6-9, 2025
Fuente
Kairos Pharma, Ltd
Editor
Business Wire
1.00
0
02/09/2025
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Web y redes sociales
Eventos
Finanzas
Kairos Pharma to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Fuente
Kairos Pharma, Ltd
Editor
Business Wire
1.00
0
16/07/2025
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Eventos
Industria
Kairos Pharma Announces Participation and Presentation in the H.C. Wainwright 27th Annual Global Investment Conference September 8-10, 2025
Fuente
Kairos Pharma, Ltd
Editor
Business Wire
1.00
0
15/07/2025
Ciencia
Medicina - Varios
Sanidad
Biotecnología
Farmacéutica
Salud
Oncología
Industria
Kairos Pharma Announces Positive Safety Results from Phase 2 Trial of ENV-105 in Advanced Prostate Cancer
Fuente
Kairos Pharma, Ltd
Editor
Business Wire
1.00
0
03/06/2025
Ciencia
Biotecnología
Sanidad
Salud
Farmacéutica
Oncología
Industria
Kairos Pharma Ltd. Announces New Data on Small Molecule GITR Ligand Agonist KROS 101 as Promising Cancer Immunotherapy at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting
Fuente
Kairos Pharma, Ltd
Editor
Business Wire
1.00
0
28/04/2025
Eventos
Industria
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Kairos Pharma, Ltd. Announces Data to be Presented at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting
Fuente
Kairos Pharma, Ltd
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0